SARS-CoV-2 T-cell Receptor Beta Chain Variable Gene Rearrangement by Next-Generation Sequencing (BLD)

What Does This Test Measure?

The test examines the variable regions of the T-cell receptor beta chain (TCRβ) in your blood. These regions are part of the immune cells that detect and fight pathogens like SARS-CoV-2. By sequencing these regions, healthcare providers can look for specific rearrangements or mutations that indicate immune activity against the virus.

Why Might You Need This Test?

This test may be used to evaluate immune responses in people who have had COVID-19, are recovering from long COVID, or are being monitored after vaccination. It can help determine whether your immune system is effectively recognizing and responding to the virus or its remnants.

How Is the Test Performed?

A small blood sample is drawn from your arm. The sample is then processed to extract DNA from your T-cells. This DNA is sequenced using advanced next-generation sequencing technology to analyze the TCRβ variable gene regions for rearrangements or mutations linked to SARS-CoV-2 exposure.

What Are the Possible Results?

Results typically show patterns of TCRβ rearrangements that reflect your immune system’s activity. These patterns can indicate past infection, ongoing immune response, or changes due to vaccination. Interpretation is done by a healthcare provider in the context of your medical history and symptoms.